Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

NETWORK 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 66Neutropenia 16Triple Negative Breast Neoplasms 8Breast Neoplasms, Male 6Inflammatory Breast Neoplasms 4Ovarian Neoplasms 3Lung Neoplasms 3Neoplasms 2Febrile Neutropenia 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Pain 1Melanoma 1Lymphoma, Non-Hodgkin 1Locally Advanced Breast Cancer 1HER2-positive Breast Cancer 1HER2-Positive Early Stage Breast Cancer 1Fever 1Early Stage Breast Cancer 1Colorectal Neoplasms 1Chemotherapy-Induced Febrile Neutropenia 1Carcinoma, Renal Cell 1Carcinoma 1Breast Diseases 1Breast Cancer Metastatic 1Breast Cancer Female 1Adenocarcinoma 1

Interventions

Cyclophosphamide 38Paclitaxel 22Epirubicin 21Trastuzumab 20Docetaxel 20Doxorubicin 19Carboplatin 15Radiotherapy 13Taxes 11Filgrastim 11Neoadjuvant Therapy 9Bevacizumab 9Fluorouracil 8pembrolizumab 7Tamoxifen 7Albumin-Bound Paclitaxel 7Capecitabine 6pertuzumab 5Thiotepa 5Peripheral Blood Stem Cell Transplantation 5Lapatinib 5130-nm albumin-bound paclitaxel 5pegfilgrastim 4Granulocyte Colony-Stimulating Factor 4Cisplatin 4Chemotherapy, Adjuvant 4Biopsy 4tipifarnib 3eribulin 3Surgical Procedures, Operative 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × pegfilgrastim × Breast × Clear all
NCT00066443 2026-03-27

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Canadian Cancer Trials Group

Phase 1/2 Completed
93 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00856492 2017-06-27

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

SWOG Cancer Research Network

Phase 2 Completed
215 enrolled 13 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00346229 2016-03-22

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

Duke University

Phase 1 Terminated
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00310089 2013-06-20

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡